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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
06.07.2020 Prevalence of 
SARS-CoV-2 in 
Spain (ENE-
COVID): a 
nationwide, 
population-based 
seroepidemiological 
study 
The Lancet | 
Article 
 This article is 
included as is 
the first 
nationwide 
(Spain) 
population-
based study of 
seroprevalence 
estimates of 
antibodies 
against SARS-
CoV-2 at 
national and 
regional levels 
 Only approx. 
5% had C19 
antibodies with 
no differences 
by sex and 
lower 
seroprevalence 
in children 
younger than 
10 years 
 There was 
substantial 
Seroprevalence  
2 
geographical 
variability, with 
higher 
prevalence 
around Madrid 
(>10%) and 
lower in coastal 
areas (<3%) 
 95% of people 
in Spain are still 
susceptible, 
despite one of 
Europe’s most 
intense 
outbreaks 
 Herd immunity 
through natural 
infection is 
difficult to 
achieve and 
unethical, given 
the collateral 
damage of 
many deaths in 
the susceptible 
population and 
overburdening 
of health 
systems 
04.07.2020 The projected 
impact of mitigation 
and suppression 
strategies on the 
COVID-19 
epidemic in 
Senegal: A 
modelling study 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 Senegal acted 
promptly to 
contain the 
spread of 
SARS-CoV-2 
and has 
already 
significantly 
reduced 
transmission 
from 1.9 (95% 
CI 1.7-2.2) to 
1.3 (95% CI 
1.2-1.5) but has 
not full 
interrupted 
transmission 
 This study 
estimates that 
continued 
spread is likely 
to peak in 
October, and to 
overwhelm the 
healthcare 
system with an 
Mitigation, 
public health, 
healthcare 
capacity 
3 
estimated 
77,400 deaths 
(95% CI 
55,270-
100,700) 
 Enhanced 
physical 
distancing 
measures could 
reduce the 
burden on 
healthcare 
services 
 Rapid scale up 
of hospital 
capacity is 
likely to be 
needed 
02.07.2020 Tracking changes 
in SARS-CoV-2 
Spike: evidence 
that D614G 
increases infectivity 
of the COVID-19 
virus 
Cell | Article 
 A SARS-CoV-2 
variant with a 
change in an 
amino acid in 
the Spike 
protein has 
become the 
most prevalent 
form in the 
global 
pandemic with 
an increase at 
national, 
regional and 
municipal levels 
and even in 
local epidemics 
where the 
original form 
was well 
established 
 This pattern 
was highly 
statistically 
significant, 
suggesting that 
the new variant 
may have a 
fitness 
advantage with 
possible higher 
upper 
respiratory tract 
viral loads, but 
not increased 
disease 
severity 
SARS-CoV-2 
variant 
4 
 Important for a 
mechanistic 
understanding 
of the virus, 
and support of 
continuing 
surveillance of 
Spike 
mutations to aid 
in the 
development of 
immunological 
interventions 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
06.07.2020 An 
evaluation 
of COVID-
19 
serological 
assays 
informs 
future 
diagnostics 
and 
exposure 
assessment 
 Nature 
Communications 
| Article 
 A detailed comparison of 
serological COVID-19 
assays shows a wide 
diversity in assay 
performance in different 
scenarios and when 
correlated to virus 
neutralising antibodies 
  Serological 
assays 
Leadership and governance 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
 01.07.2020  Effectiveness 
of government 
policies in 
response to 
the COVID-19 
outbreak 
 SSRN 
 Assessment of the 
quantitative impact of 
government 
interventions on 
deaths related to the 
C19 outbreak 
 The greater the 
strength of 
government 
interventions at an 
early stage, the more 
 Government, 
impact 
5 
effective these are in 
slowing down or 
reversing the growth 
rate of deaths 
 Informative for future 
C19 waves and for 
other future 
pandemics  
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
July 2020 COVID-19 testing in Africa: 
lessons learnt 
The Lancet Microbe | 
Comment 
Pascale 
Ondoa et al. 
July 2020 COVID-19: a multifaceted threat 
to refugee camps 
The Lancet Microbe | News Talha Burki 
July 2020 Development of potential COVID-
19 vaccines continues to 
accelerate 
The Lancet Microbe | News Tony Kirby 
06.07.2020 The Indirect Health Effects of 
COVID-19: long-term costs for 
health systems 
CGD | Blog Lydia Regan 
Y-Ling Chi 
06.07.2020 WHO: access to HIV medicines 
severely impacted by COVID-19 
as AIDS response stalls 
WHO | News  
06.07.2020 SARS-CoV-2 seroprevalence in 
COVID-19 hotspots 
The Lancet | Comment Isabella 
Eckerle 
Benjamin 
Meyer 
03.07.2020 Six months of coronavirus: the 
mysteries scientists are still racing 
to solve 
Nature | News Ewen 
Callaway 
Heidi Ledford 
Smriti 
Mallapaty 
6 
03.07.2020 Oxygen availability in sub-
Saharan African countries: a call 
for data to inform service delivery 
The Lancet Global 
Health  Correspondence 
Sowmya 
Mangipudi 
Andrew 
Leather 
Ahmed 
Seedat 
Justine 
Davies 
03.07.2020 Pulse oximetry in low-resource 
settings during the COVID-19 
pandemic 
The Lancet Global Health | 
Correspondence 
Nicola Starr et 
al. 
03.07.2020 Decisive leadership is a necessity 
in the COVID-19 response 
The Lancet | Comment Ahmed 
Mohammed 
Obaid Al Saidi 
et al. 
01.07.2020 How to predict – and prevent – the 
next pandemic 
The Economist | Weekly 
podcast (24 min) 
 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
01.05.2020 COVID-19 
considerations for 
home and community 
care 
SSHAP 
 This review gives an overview of 
existing guidance and models for 
home and community-based care 
for C19, with an emphasis on 
LMICs 
 Gaps in the guidance are assessed 
and ways these may be addressed 
suggested. This includes 
highlighting innovative examples 
and drawing on knowledge of past 
outbreaks 
 Recommendations are aimed at 
governments, NGOs and relevant 
community-based organisations  
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Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
 COVID-
19 
Vaccine 
Tracker 
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
8 
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability 
and inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
9 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
 Epidemic 
Preparedne
ss 
Innovations 
  Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
COVID-19 
Digest 
Health 
Policy and 
Planning  
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Government 
JAMA 
Network 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The 
Lancet 
 HEART     
UNESCO   medRxiv 
and 
bioRxiv 
(Preprints) 
 UKRI     
UN WFP   NEJM  Evidence Aid     
GOARN   Oxford 
University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
    
10 
World Bank   SAGE 
journals 
 Prevent 
Epidemics  
    
Our World in 
Data 
  Science       
COVID-19 
Narratives by 
David Nabarro 
  Springer 
Nature 
      
Reliefweb   SSRN 
(Preprints)  
      
Humanitarian 
OpenStreetMap 
Team 
  Wiley       
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
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Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
07.07.2020 
1300-1430 
BST 
Fifth Annual Health 
Financing Forum 
(AHFF): Health 
Financing Resilience 
and Sustainability 
Online event 1h 30 JLN, WB, USAID, 
GFF, GFF, CGD 
30.06.2020 
1000 BST 
Clinical update: 
dexamethasone and 
hydroxychloroquine for 
treatment of severe 
COVID-19  
Webinar   African Academy of 
Sciences 
26.06.2020 
0900 to 
1030 EDT 
Monitoring and 
mitigating the collateral 
effects of COVID-19 
Online event 1h 30 CGD 
13 July 
3:00 PM – 
6:00 PM 
BST 
2020 UCL-Lancet 
Lecture: Global Health 
Preparedness by Dr 
Muhammad Pate, 
Global Director for 
Health, Nutrition and 
Population at the World 
Bank Group 
Online 
Lecture  
2 hour 
lecture, 1 
hour panel 
discussion 
UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
24-
25.06.2020 
Africa’s leadership role 
in COVID-19 vaccine 
development and 
access 
Zoom webinar   African Union & Africa 
CDC 
12 
Available 
now 
Standard precautions: 
Environmental cleaning 
and disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: Pandemics, 
Modelling and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn 
UNESCO UNITWIN 
Complex Systems 
Digital Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr 
Peter Lachman, Dr 
Teri Rynolds & Dr Ed 
Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence Weeks 5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays 
at 1700 
CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open online 
brief with Dr David 
Nabarro 
Event 1h 4SD 
13 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods for 
detection, prevention, 
response and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to COVID-
19: Real-time training 
for the coronavirus 
disease outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling the 
Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour weekly 
study 
FutureLearn 
University of 
Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
